Price T Rowe Associates Inc Monte Rosa Therapeutics, Inc. Transaction History

Price T Rowe Associates Inc

$867 Billion
Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Monte Rosa Therapeutics, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 7,116,637 shares of GLUE stock, worth $44.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

7,116,637

Previous 6,601,141 7.81%

Holding current value

$44.3 Million

Previous $35 Million 41.17%

% of portfolio

0.01%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$4.8 - $10.36 $2.47 Million - $5.34 Million	515,496 Added 7.81%	7,116,637 $49.4 Million
Q3 2024 Nov 14, 2024	BUY	$3.59 - $6.97 $2.24 Million - $4.35 Million	623,554 Added 10.43%	6,601,141 $35 Million
Q2 2024 Aug 14, 2024	BUY	$3.38 - $7.86 $2.98 Million - $6.92 Million	880,800 Added 17.28%	5,977,587 $22.4 Million
Q1 2024 May 15, 2024	BUY	$4.26 - $8.46 $664,048 - $1.32 Million	155,880 Added 3.15%	5,096,787 $35.9 Million
Q4 2023 Feb 14, 2024	BUY	$2.5 - $5.93 $2.68 Million - $6.35 Million	1,070,360 Added 27.65%	4,940,907 $27.9 Million
Q3 2023 Nov 14, 2023	SELL	$4.78 - $7.22 $124,045 - $187,366	-25,951 Reduced 0.67%	3,870,547 $18.5 Million
Q2 2023 Aug 14, 2023	BUY	$4.53 - $8.4 $919,608 - $1.71 Million	203,004 Added 5.5%	3,896,498 $26.7 Million
Q1 2023 May 15, 2023	BUY	$5.95 - $8.21 $59,880 - $82,625	10,064 Added 0.27%	3,693,494 $28.8 Million
Q4 2022 Feb 14, 2023	SELL	$6.71 - $9.72 $536,504 - $777,172	-79,956 Reduced 2.12%	3,683,430 $28 Million
Q3 2022 Nov 14, 2022	SELL	$7.17 - $12.16 $10.7 Million - $18.1 Million	-1,485,749 Reduced 28.3%	3,763,386 $30.7 Million
Q2 2022 Aug 15, 2022	SELL	$6.15 - $14.99 $625,996 - $1.53 Million	-101,788 Reduced 1.9%	5,249,135 $50.8 Million
Q1 2022 May 16, 2022	BUY	$10.36 - $20.41 $12.5 Million - $24.6 Million	1,204,004 Added 29.03%	5,350,923 $75 Million
Q4 2021 Feb 14, 2022	BUY	$16.28 - $27.15 $16.3 Million - $27.1 Million	999,985 Added 31.78%	4,146,919 $84.7 Million
Q3 2021 Nov 15, 2021	BUY	$18.59 - $42.21 $7.61 Million - $17.3 Million	409,280 Added 14.95%	3,146,934 $69.3 Million
Q2 2021 Aug 16, 2021	BUY	$18.86 - $22.7 $51.6 Million - $62.1 Million	2,737,654 New	2,737,654 $61.3 Million

Others Institutions Holding GLUE

# of Institutions

107

Shares Held

53.8M

Call Options Held

276K

Put Options Held

15.9K

View Full List

About Monte Rosa Therapeutics, Inc.

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $291M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

More about GLUE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Monte Rosa Therapeutics, Inc. Transaction History